Elevance Health Inc.

Elevance Health Inc.

ELV
Elevance Health Inc.US flagNew York Stock Exchange
392.67
USD
+3.64
- -
85.27BMarket Cap
Elevance Health Inc.
ELV
(New York Stock Exchange)

Recent

price

392.67

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
155.4
178.89
201.82
242.17
275.54
303.01
321.76
351.6
357.83
412.04
496.6
573.43
658.08
735.14
777.26
902.15
905.87
Revenue per Share
7.64
7.8
8.71
8.49
9.58
9.8
9.37
15.01
14.57
19.01
18.63
25.47
24.77
25.69
26.29
25.65
23.7
Basic EPS, GAAP
2.56
8.41
7.22
8.2
9.9
13.68
10.18
13.25
10.18
19.71
39.39
30.1
30.45
29.03
20.01
14.38
29.15
Free Cash Flow per Basic Share
- -
1.05
1.2
1.53
1.79
2.51
2.59
2.75
3.01
3.23
3.89
4.57
5.16
5.99
6.63
6.93
6.87
Dividend per Share
28.39
33.87
41.51
47.11
52.28
56.58
62.8
70.51
77.67
89.26
97
112.05
124.6
136.23
147.49
160.36
161.81
Book Value per Share
6.75
4.41
-5.75
-2.02
-2.94
-10.24
-1.61
-4.28
-3.77
10.1
8.57
5.31
6.86
16.37
4.64
20.31
20.83
Tangible Book Value per Share
378
339
305
293
268
261
264
256
257
253
245
242
238
233
227
221
221
Basic Weighted Avg Shares
58,698
60,711
61,497
71,024
73,874
79,156
84,863
90,040
92,105
104,213
121,867
138,639
156,595
171,340
176,810
199,125
200,415
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
601
637
741
909
851
908
912
891
1,132
1,133
1,154
1,302
1,675
1,745
1,393
1,546
1,527
Depreciation Expense
2,887
2,647
2,656
2,490
2,570
2,560
2,470
3,843
3,750
4,807
4,572
6,158
5,894
5,987
5,980
5,662
5,243
Net Income, GAAP
33.69
33.13
31.29
31.4
41.39
44.72
45.77
3.05
26.01
19.68
26.71
23.09
22.53
22.35
24.46
15.63
15.76
Effective Tax Rate (%)
4.92
4.36
4.32
3.51
3.48
3.23
2.91
4.27
4.07
4.61
3.75
4.44
3.76
3.49
3.38
2.84
2.62
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
8,148
8,466
14,171
13,574
14,020
15,324
14,358
17,382
17,217
17,787
19,335
21,157
22,349
23,246
29,218
30,797
30,768
LT Debt
23,813
23,288
23,803
24,765
24,251
23,044
25,100
26,503
28,541
31,728
33,199
36,128
36,330
39,405
41,426
44,026
44,042
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
16.8
14.31
12.28
10.38
10.19
9.78
9.1
12.98
11.16
13.21
11.9
14.42
12.61
12.24
11.3
10.33
9.73
Return on Capital (%)
28.4
23.82
22
18.81
18.46
17.78
15.76
22.2
19.71
22.59
19.71
24.2
20.78
19.5
18.31
16.42
14.91
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
929
1,249
1,074
LT Borrowings
31,173
30,797
30,768
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
222
221
217
Market Capitalization
72,701
78,281
64,768

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
34,996
35,375
35,562
Accounts Receivable, Net
9,535
10,073
11,525
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
23,233
24,406
24,634
ST Debt
929
1,249
1,074
Deferred Revenue
1,831
1,493
1,759

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.73%
5.85%
6.28%
Free Cash Flow
6.82%
-18.95%
-30.27%
Net Income, GAAP
9.95%
5.31%
-5.32%
Sales/Revenue/Turnover
9.76%
10.39%
12.62%
Total Cash Common Dividend
8.94%
10.01%
1.39%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
42,577
43,646
45,145
45,442
176,810
2025
48,891
49,776
50,711
49,747
199,125
2026
50,181
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
9.65
9.92
4.38
1.84
26.29
2025
9.67
7.75
5.35
2.48
25.65
2026
8.12
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.63
1.63
1.63
1.64
6.63
2025
1.71
1.71
1.72
1.71
6.93
2026
1.73
- -
- -
- -
- -
Business
Elevance Health Inc. (NYSE: ELV) operates as a leading health benefits company in the United States, providing a comprehensive portfolio of medical, dental, vision, pharmaceutical, behavioral health, long-term care, disability, and life insurance plans through affiliated brands including Anthem Blue Cross and Blue Shield in 14 states, Wellpoint Medicaid plans, Carelon services, Amerigroup, and others; it also delivers advanced healthcare solutions such as pharmacy benefit management via CarelonRx, clinical care coordination, digital health tools, primary care enablement, and whole-person care addressing social drivers of health. Headquartered in Indianapolis, Indiana, the company traces its origins to 1946 through predecessor entities like Anthem and WellPoint, which merged in 2004, and rebranded from Anthem Inc. to Elevance Health in June 2022 to reflect its focus on elevating health outcomes. Elevance Health serves approximately 47 million medical members nationwide, with operations spanning commercial employer-sponsored plans, individual coverage, Medicare Advantage, and Medicaid programs across multiple states including California, Florida, Georgia, Indiana, Kentucky, Missouri, New York, Ohio, Texas, and Puerto Rico via subsidiaries like MMM; it targets employers, individuals, families, government programs, and complex-needs populations through segments encompassing Health Benefits, CarelonRx, Carelon Services, and other corporate activities. The company has pursued aggressive expansion in specialty care and home-based services, including the 2024 acquisition of Paragon Healthcare for infusion therapies and CareBridge for home health management; it acquired Kroger Specialty Pharmacy in 2024 to bolster CarelonRx's infusion and mail-order capabilities, alongside earlier purchases of BioPlus Specialty Pharmacy and opening new dispensing centers. In April 2024, Elevance Health formed a strategic partnership with Clayton, Dubilier & Rice, integrating Carelon Health assets with apree health and Millennium Physician Group to innovate primary care delivery across U.S. regions. Recent initiatives encompass expanding behavioral health interventions and external partnerships under Carelon to manage medical costs, deepening AI integrations via a partnership with OpenAI announced in Q3 2025, scaling pharmacy home delivery and specialty services, enhancing Star ratings through member engagement, and broadening access to doula care and histotripsy treatments for liver tumors for over 45 million members; the company also rebranded Amerigroup to Wellpoint in 2024 and continues investing in digital automation and value-based care principles to drive long-term growth amid Medicaid dynamics.

Company News

APIChat
  • Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade)

  • Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide

  • Elevance Health (ELV) Up 12.6% Since Last Earnings Report: Can It Continue?

  • AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers

  • Is ELV Undervalued? DCF Says Worth $643

  • Elevance Health, Inc. (ELV) Shareholder/Analyst Call Prepared Remarks Transcript

  • A Look at Elevance Health Inc (ELV) After 4.0% Gain -- GF Value $518.29 vs Price $393.30

  • Is ELV Undervalued? DCF Says Worth $643

  • Is ELV Undervalued? DCF Says Worth $643

  • Major health insurers show signs of recovery – but a key test looms

  • This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

  • Elevance Health Advances Efforts to Close Critical Gaps in Mental Health Care

  • Elevance Health Names Best in Class Primary Care Practices in Care Provider Recognition Program

  • Elevance Health's Affiliated Health Plans Deliver More Predictable, Lower Healthcare Costs for Small Businesses

  • Comerica Bank Sells 2,331 Shares of Elevance Health, Inc. $ELV

  • Centene Q1 Earnings Beat Estimates on Rising Premiums, 2026 View Up

  • UHS' Q1 Earnings Beat on Strong Behavioral Health Care Admissions

  • Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?

  • Elevance Health Inc (ELV) Shares Surge 3.3% -- What GF Score of 76 Tells Investors

  • Cornerstone Investment Partners LLC Sells 2,136 Shares of Elevance Health, Inc. $ELV